Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Matched observational study of 2010-2021 Veterans Health Administration data finds MGUS associated with higher 10-yr cardiovascular disease incidence (29.5% vs 9.7%; P<0.001) & risk (aHR, 1.70 [95% CI, 1.62-1.78]; P<0.001).”
Title: Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study
Authors: Tzeyu L. Michaud, Mei Wang, Daphne R. Friedman, Lawrence Liu, Theodore S. Thomas, Kristen M. Sanfilippo, Graham A. Colditz, Martin W. Schoen, and SuâHsin Chang
You can read the Full Article in the Journal of the American Heart Association.
You can find more posts featuring Robert Orlowski on OncoDaily.
